Market cap
$493 Mln
Revenue (TTM)
$231 Mln
P/E Ratio
18.4
P/B Ratio
3.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 26.08 | 7.75 | -2.86 | 0.16 | -1.93 |
| EBIT | 412.50 | 5.29 | -33.31 | 46.12 | 29.80 |
| Net Profit | 318.20 | 39.86 | -44.86 | 64.11 | 22.54 |
| EPS | 310.93 | 33.34 | -47.32 | 124.41 | 20.87 |
| Book Value | -- | -- | 35.68 | 75.05 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 16.57 | 9.73 | 15.00 | 18.57 | 15.86 |
| Net Margin
| -- | -6.17 | 11.55 | -- | -- |
| Return on equity
| 42.37 | 164.17 | 19.87 | 27.97 | 41.60 |
| Return on Capital
| 17.26 | 5.27 | -- | 19.14 | 18.29 |
| Return on Assets
| 12.56 | 5.06 | 10.34 | 14.48 | 13.64 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.22 | 0.80 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
19.14
|
18.29
|
14.35
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
19.87
Higher than Peers by 60.27
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
19.87
|
27.97
|
41.60
|
57.54
|
0.02
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
10.34
Higher than Peers by 41.32
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
10.34
|
14.48
|
13.64
|
9.54
|
0.00
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
15.00
Higher than Peers by 98.62
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
15.00
|
18.57
|
15.86
|
15.28
|
5.28
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
11.55
Higher than Peers by 104.22
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
11.55
|
13.62
|
13.14
|
9.16
|
0.00
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-2.86
Lower than Peers by 56.82
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
-2.86
|
-0.01
|
-0.02
|
0.03
|
-0.10
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-33.31
Lower than Peers by 32.51
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
-33.31
|
16.01
|
1.52
|
198.81
|
175.33
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
-44.86
Lower than Peers by 37.55
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
-44.86
|
2.75
|
40.23
|
1,079,450.00
|
100.01
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
-47.32
Lower than Peers by 61.97
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
-47.32
|
-0.01
|
0.36
|
10,213.48
|
1.00
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
26.13
Higher than Peers by 36.31
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
26.13
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
0.22
|
0.80
|
2.09
|
5.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
0.00
|
0.18
|
0.55
|
0.73
|
0.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.91
Lower than Peers by 2.90
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
2.91
|
2.00
|
1.54
|
1.57
|
1.73
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
2.64
Lower than Peers by 3.05
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
2.64
|
1.93
|
1.45
|
1.50
|
1.67
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
9.86
Higher than Peers by 11.95
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
9.86
|
6.40
|
2.94
|
2.70
|
1.04
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.73
Lower than Peers by 4.41
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
14.73
|
23.49
|
13.89
|
20.58
|
18.54
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.90
Higher than Peers by 0.83
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
0.90
|
1.06
|
1.04
|
1.04
|
1.02
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
68.51
|
63.79
|
70.34
|
59.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
44.71
|
44.81
|
33.81
|
38.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
33.18
|
35.16
|
38.83
|
58.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
80.04
|
73.45
|
65.32
|
40.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
18.37
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
18.37
|
9.85
|
4.98
|
9.63
|
96,897.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
3.44
Lower than Peers by 1.74
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
3.44
|
2.35
|
1.64
|
3.89
|
8.97
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
8.77
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
8.77
|
4.45
|
2.58
|
4.70
|
10.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
493
Higher than Peers by 347
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Puma Biotechnology (PBYI)
|
493
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|